{"filing":{"accession_number":"0001104659-26-076648","cik":"0001000694","ticker":"NVAX","company_name":"NOVAVAX INC","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"tm2618472d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076648/tm2618472d1_8k.htm"},"events":[{"id":13006,"run_id":11546,"accession_number":"0001104659-26-076648","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure presents the final voting results from Novavax's June 18, 2026 Annual Meeting of Stockholders, including election of three Class I directors, advisory approval of named executive officer compensation, amendments to two equity incentive plans, and ratification of Ernst \u0026 Young LLP as independent auditor. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms governance outcomes and shareholder approval of key compensation and equity plan matters.","company_name":"NOVAVAX INC","ticker":"NVAX","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10020,"accession_number":"0001104659-26-076648","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from Novavax's June 18, 2026 Annual Meeting of Stockholders, including election of three Class I directors, advisory approval of named executive officer compensation, amendments to two equity incentive plans, and ratification of Ernst \u0026 Young LLP as independent auditor. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms governance outcomes and shareholder approval of key compensation and equity plan matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T12:01:51.757343+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10020,"accession_number":"0001104659-26-076648","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from Novavax's June 18, 2026 Annual Meeting of Stockholders, including election of three Class I directors, advisory approval of named executive officer compensation, amendments to two equity incentive plans, and ratification of Ernst \u0026 Young LLP as independent auditor. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms governance outcomes and shareholder approval of key compensation and equity plan matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T12:01:51.757343+00:00","company_name":"NOVAVAX INC","ticker":"NVAX","filing_date":"2026-06-23"}]}